Clinical Trial Update: Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata [NA]

View source ↗

Summary

This clinical trial is recruiting to compare intralesional triamcinolone versus Candida albicans antigen for Alopecia Areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Candida albicans antigen (Candida albicans antigen)
• Triamcinolone acetonide (intralesional) (triamcinolone acetonide)

Snippet

Sponsor: Universidad Autonoma de Nuevo Leon | Conditions: Alopecia Areata | NA | Status: RECRUITING